开拓创新·关爱人生
万邦德制药集团—专业从事现代中药、化学原料药及其制剂研发、生产和销售的高新技术企业
R&D
All categories
Academician Expert Workstation
In October 2015 Wepon Pharmaceutical Group reached a cooperation with Shanghai Institute of Materia Medica, Chinese Academy of Sciences and established the "Academician Expert Workstation"
The Academician and Expert Workstation is led by Tang Xican, an academician of the Chinese Academy of Engineering, a doctoral supervisor, and a researcher at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, to form a high-level talent team. It has achieved fruitful results and has successively obtained 10 invention patents in China, the United States, Japan and the European Union.
In November 2018, it was rated as“National Model Academician and Expert Workstation”
Academician Profile
Tang Xican
Academician of the Chinese Academy of Engineering\doctoral supervisor
Researcher, Shanghai Institute of Materia Medica, Chinese Academy of Sciences\Editor-in-chief of Chinese Journal of New Drugs and Clinical Medicine
Research direction
Development of active natural products for central nervous system diseases
-
50
+Engaged in the discovery of active ingredients in Chinese herbal medicines that act on the nervous system and their mechanism of action
-
200
+The research team he leads has so far published research papers in famous international and domestic academic journals
-
68
Among them, Huperzine A series research papers were published
-
3
Domestic invention patent
-
4
International Patent
The projects completed as the principal investigator have won７national awards,３provincial and ministerial science and technology first prizes,１international science and technology award,１Ho Leung Ho Lee Science and Technology Award and１Chinese Medicine Development Award Special Contribution Award.
Main work content at the workstation
Assisted in advancing the company's research on the anti-senile dementia drug Huperzine A.
A comparative study on the pharmacological and pharmacological effects of Huperzine A synthesis and natural Huperzine A.
Preclinical pharmacology and pharmacodynamics study of Huperzine A intramuscular injection.
Team member
Zhang Haiyan
Participated in the research and development of AD treatment drugs Huperzine A and Cyprin. Responsible for the overall plan design and guidance of the Chinese pharmacology and efficacy research of the project
Huang Xiaotian
In the academician team, he is the specific person in charge of the pharmacology and pharmacodynamics research project, responsible for the specific program design, method determination and specific implementation.
Wang Huan
In the academician team, he is responsible for the comparison of the efficacy, selectivity and kinetic data of cholinesterase inhibition in vitro and in vivo.
Fu Yan
The academician team is responsible for the behavioral comparison of scopolamine and APP/PSI transgenic animals and the detection of related enzymatic indicators.
Gong Qi
The academician team is responsible for the behavioral comparison of scopolamine and APP/PSI transgenic animals and the detection of related enzymatic indicators.
Cooperative contents
Copyright 2016 © wanbang.com.cn All Rights Reserved.
Internet drug information service qualification certificate :(zhejiang) - non-operating -2023-0143 Powered by 300.cn
